feed,title,long_url,short_url
Benzinga,"EXCLUSIVE: Coya Therapeutics, Focused On Neurodegenerative Diseases Has Gained 70% Since IPO; CEO Highlights Efforts On Combination Therapy For Rare Diseases",https://benzinga.com/general/biotech/24/05/39027945/exclusive-coya-therapeutics-focused-on-neurodegenerative-diseases-has-gained-70-since-ipo-ceo-hig,https://da.gd/UncEK
